Pîrlog, C.-F.; Paroșanu, A.I.; Slavu, C.O.; Olaru, M.; Popa, A.M.; Iaciu, C.; Niță, I.; Moțatu, P.; Horia, C.; Manolescu, L.S.C.;
et al. Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature. Curr. Oncol. 2022, 29, 9428-9436.
https://doi.org/10.3390/curroncol29120741
AMA Style
Pîrlog C-F, Paroșanu AI, Slavu CO, Olaru M, Popa AM, Iaciu C, Niță I, Moțatu P, Horia C, Manolescu LSC,
et al. Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature. Current Oncology. 2022; 29(12):9428-9436.
https://doi.org/10.3390/curroncol29120741
Chicago/Turabian Style
Pîrlog, Cristina-Florina, Andreea Ioana Paroșanu, Cristina Orlov Slavu, Mihaela Olaru, Ana Maria Popa, Cristian Iaciu, Irina Niță, Pompilia Moțatu, Cotan Horia, Loredana Sabina Cornelia Manolescu,
and et al. 2022. "Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature" Current Oncology 29, no. 12: 9428-9436.
https://doi.org/10.3390/curroncol29120741
APA Style
Pîrlog, C. -F., Paroșanu, A. I., Slavu, C. O., Olaru, M., Popa, A. M., Iaciu, C., Niță, I., Moțatu, P., Horia, C., Manolescu, L. S. C., & Nițipir, C.
(2022). Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature. Current Oncology, 29(12), 9428-9436.
https://doi.org/10.3390/curroncol29120741
